Community physicians’ attitudes towards meetings with representatives of pharmaceutical companies: a pilot study
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2052-3211
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Community physicians’ attitudes towards meetings with representatives of pharmaceutical companies: a pilot study ; volume:16 ; number:1 ; day:25 ; month:1 ; year:2023 ; pages:1-8 ; date:12.2023
Journal of pharmaceutical policy and practice ; 16, Heft 1 (25.1.2023), 1-8, 12.2023
- Urheber
-
Koplovitz, Amit
Freud, Tamar
Peleg, Roni
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s40545-023-00521-8
- URN
-
urn:nbn:de:101:1-2023040309385910805361
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.20252025, 01:47 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Koplovitz, Amit
- Freud, Tamar
- Peleg, Roni
- SpringerLink (Online service)
Ähnliche Objekte (12)
Interaction and medical inducement between pharmaceutical representatives and physicians: a meta-synthesis
Meetings of the House of Representatives
Regulating pharmaceutical companies’ financial largesse
Representatives
Medicines information provided by pharmaceutical representatives: a comparative study in Australia and Malaysia
The effect of pharmaceutical companies’ marketing mix strategies on physicians prescribing practices in Jordan: a cross-sectional study
Grand Representatives
Regulating the relationship between physicians and pharmaceutical companies: a qualitative and descriptive analysis of the impact of Israeli legislation
Physicians’ attitudes towards disclosure of payments from pharmaceutical companies in a nationwide voluntary transparency database: a cross-sectional survey
Voters and Representatives: How Should Representatives Be Selected?
Changing R&D models in research-based pharmaceutical companies
Strategic Patenting by Pharmaceutical Companies – Should Competition Law Intervene?
Interaction and medical inducement between pharmaceutical representatives and physicians: a meta-synthesis
Meetings of the House of Representatives
Regulating pharmaceutical companies’ financial largesse
Representatives
Medicines information provided by pharmaceutical representatives: a comparative study in Australia and Malaysia
The effect of pharmaceutical companies’ marketing mix strategies on physicians prescribing practices in Jordan: a cross-sectional study
Grand Representatives
Regulating the relationship between physicians and pharmaceutical companies: a qualitative and descriptive analysis of the impact of Israeli legislation
Physicians’ attitudes towards disclosure of payments from pharmaceutical companies in a nationwide voluntary transparency database: a cross-sectional survey
Voters and Representatives: How Should Representatives Be Selected?
Changing R&D models in research-based pharmaceutical companies
Strategic Patenting by Pharmaceutical Companies – Should Competition Law Intervene?
Interaction and medical inducement between pharmaceutical representatives and physicians: a meta-synthesis
Meetings of the House of Representatives
Regulating pharmaceutical companies’ financial largesse
Representatives
Medicines information provided by pharmaceutical representatives: a comparative study in Australia and Malaysia
The effect of pharmaceutical companies’ marketing mix strategies on physicians prescribing practices in Jordan: a cross-sectional study
Grand Representatives
Regulating the relationship between physicians and pharmaceutical companies: a qualitative and descriptive analysis of the impact of Israeli legislation
Physicians’ attitudes towards disclosure of payments from pharmaceutical companies in a nationwide voluntary transparency database: a cross-sectional survey
Voters and Representatives: How Should Representatives Be Selected?
Changing R&D models in research-based pharmaceutical companies